Cargando…

Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment

OBJECTIVE: Uncovering genetic and immunologic tumor features is critical to gain insights into the mechanisms of immunotherapeutic response. Herein, this study observed the functions of CXCR2 in prognosis and immunology of ovarian cancer. METHODS: Expression, prognostic significance, and genetic mut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Haizhou, Ren, Mi, Liu, Tongyu, Sun, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626184/ https://www.ncbi.nlm.nih.gov/pubmed/34840630 http://dx.doi.org/10.1155/2021/5350232

Ejemplares similares

Treg: A Promising Immunotherapeutic Target in Oral Diseases
por: Zhang, Yujing, et al.
Publicado: (2021)

T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
por: Zhou, Qi, et al.
Publicado: (2020)

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
por: Mohamed Khosroshahi, Leila, et al.
Publicado: (2021)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments
por: Chu, Emily, et al.
Publicado: (2023)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma
por: Pi, Yilin, et al.
Publicado: (2022)

Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
por: Feng, Wei, et al.
Publicado: (2023)

Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment
por: Teow, Sin-Yeang, et al.
Publicado: (2017)

Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
por: Xue, Qianqian, et al.
Publicado: (2023)

Immunotherapeutic and their immunological aspects: Current treatment strategies and agents
por: Jain, Mayank, et al.
Publicado: (2022)

Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
por: Mihályová, Jana, et al.
Publicado: (2021)

Immunotherapeutic approaches to ovarian cancer treatment
por: Chester, Cariad, et al.
Publicado: (2015)

The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis
por: Liu, Cheng-Fei, et al.
Publicado: (2014)

Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment
por: Milardi, Giulia, et al.
Publicado: (2023)

An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
por: Yang, Kai, et al.
Publicado: (2018)

Prognostic significance of CXCR4 expression in acute myeloid leukemia
por: Du, Wen, et al.
Publicado: (2019)

Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
por: Xu, Jun, et al.
Publicado: (2023)

Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy
por: Pangilinan, Christian Ronquillo, et al.
Publicado: (2019)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target
por: Pierini, Stefano, et al.
Publicado: (2020)

CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2021)

Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning
por: Wolf, Dominik, et al.
Publicado: (2014)

Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities
por: de Carvalho Lima, Elidamar Nunes, et al.
Publicado: (2022)

Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis
por: Zhao, Zhixun, et al.
Publicado: (2022)

GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation
por: Liang, Xuexia, et al.
Publicado: (2023)

Prognostic significance of CXCR7 in cancer patients: a meta-analysis
por: Fan, Huiqian, et al.
Publicado: (2018)

Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
por: Wu, Yanlin, et al.
Publicado: (2023)

Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer
por: Li, Jia, et al.
Publicado: (2014)

Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Fc Receptor-Like 1 as a Promising Target for Immunotherapeutic Interventions of B-Cell-Related Disorders
por: Yousefi, Zahra, et al.
Publicado: (2019)

LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
por: Zweytick, Dagmar
Publicado: (2019)

Immunomodulatory activity of manganese dioxide nanoparticles: Promising for novel vaccines and immunotherapeutics
por: Huang, Yuhe, et al.
Publicado: (2023)

Immunotherapeutic Targeting in Autoimmune Diseases
por: Janikashvili, Nona, et al.
Publicado: (2016)

LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2022)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_repjmj8bqkmd9dtc7lh25mvb51